Cargando…

The effect of repeated remote ischemic postconditioning on infarct size in patients with an ischemic stroke (REPOST): study protocol for a randomized clinical trial

BACKGROUND: Remote ischemic postconditioning (rIPostC) refers to the observation that repeated, short periods of ischemia protect remote areas against tissue damage during and after prolonged ischemia. Based on previous observations of a potential neuroprotective effect of rIPostC, the aim of this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Landman, Thijs, Schoon, Yvonne, Warlé, Michiel, De Leeuw, Frank-Erik, Thijssen, Dick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419836/
https://www.ncbi.nlm.nih.gov/pubmed/30876432
http://dx.doi.org/10.1186/s13063-019-3264-0
_version_ 1783404007885111296
author Landman, Thijs
Schoon, Yvonne
Warlé, Michiel
De Leeuw, Frank-Erik
Thijssen, Dick
author_facet Landman, Thijs
Schoon, Yvonne
Warlé, Michiel
De Leeuw, Frank-Erik
Thijssen, Dick
author_sort Landman, Thijs
collection PubMed
description BACKGROUND: Remote ischemic postconditioning (rIPostC) refers to the observation that repeated, short periods of ischemia protect remote areas against tissue damage during and after prolonged ischemia. Based on previous observations of a potential neuroprotective effect of rIPostC, the aim of this study is to evaluate whether repeated rIPostC after an ischemic stroke can reduce infarct size, which could be translated to an improvement in clinical outcomes. METHODS/DESIGN: We will enroll 200 ischemic stroke patients to daily rIPostC or sham conditioning during hospitalization into a randomized single-blind placebo-controlled trial. The intervention consists of twice daily exposure to four cycles of 5-min cuff inflation around the upper arm to > 20 mmHg above systolic blood pressure (i.e., rIPostC) or 50 mmHg (i.e., control), followed by 5 minutes of deflation. The primary outcome is infarct size, measured using an MRI diffusion-weighted image at the end of hospitalization. Secondary outcomes include the Modified Rankin Scale, National Institutes of Health Stroke Scale, quality of life, and cardiovascular and cerebrovascular morbidity and mortality. To explore possible underlying mechanisms of rIPostC, venous blood will be sampled to assess biomarkers of inflammation and vascular health. DISCUSSION: Previous studies in animals and humans, using a single bout of remote ischemic conditioning, report a potential effect of rIPostC in attenuating neural damage. Although repeated rIPostC has been investigated for cardiovascular disease patients and preclinical stroke models, no previous study has explored the potential physiological and clinical effects of repeatedly applying rIPostC during the hospitalization phase after a stroke. TRIAL REGISTRATION: Netherlands Trial Register, NTR6880. Registered on 8 December 2017. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13063-019-3264-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6419836
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64198362019-03-28 The effect of repeated remote ischemic postconditioning on infarct size in patients with an ischemic stroke (REPOST): study protocol for a randomized clinical trial Landman, Thijs Schoon, Yvonne Warlé, Michiel De Leeuw, Frank-Erik Thijssen, Dick Trials Study Protocol BACKGROUND: Remote ischemic postconditioning (rIPostC) refers to the observation that repeated, short periods of ischemia protect remote areas against tissue damage during and after prolonged ischemia. Based on previous observations of a potential neuroprotective effect of rIPostC, the aim of this study is to evaluate whether repeated rIPostC after an ischemic stroke can reduce infarct size, which could be translated to an improvement in clinical outcomes. METHODS/DESIGN: We will enroll 200 ischemic stroke patients to daily rIPostC or sham conditioning during hospitalization into a randomized single-blind placebo-controlled trial. The intervention consists of twice daily exposure to four cycles of 5-min cuff inflation around the upper arm to > 20 mmHg above systolic blood pressure (i.e., rIPostC) or 50 mmHg (i.e., control), followed by 5 minutes of deflation. The primary outcome is infarct size, measured using an MRI diffusion-weighted image at the end of hospitalization. Secondary outcomes include the Modified Rankin Scale, National Institutes of Health Stroke Scale, quality of life, and cardiovascular and cerebrovascular morbidity and mortality. To explore possible underlying mechanisms of rIPostC, venous blood will be sampled to assess biomarkers of inflammation and vascular health. DISCUSSION: Previous studies in animals and humans, using a single bout of remote ischemic conditioning, report a potential effect of rIPostC in attenuating neural damage. Although repeated rIPostC has been investigated for cardiovascular disease patients and preclinical stroke models, no previous study has explored the potential physiological and clinical effects of repeatedly applying rIPostC during the hospitalization phase after a stroke. TRIAL REGISTRATION: Netherlands Trial Register, NTR6880. Registered on 8 December 2017. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13063-019-3264-0) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-15 /pmc/articles/PMC6419836/ /pubmed/30876432 http://dx.doi.org/10.1186/s13063-019-3264-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Landman, Thijs
Schoon, Yvonne
Warlé, Michiel
De Leeuw, Frank-Erik
Thijssen, Dick
The effect of repeated remote ischemic postconditioning on infarct size in patients with an ischemic stroke (REPOST): study protocol for a randomized clinical trial
title The effect of repeated remote ischemic postconditioning on infarct size in patients with an ischemic stroke (REPOST): study protocol for a randomized clinical trial
title_full The effect of repeated remote ischemic postconditioning on infarct size in patients with an ischemic stroke (REPOST): study protocol for a randomized clinical trial
title_fullStr The effect of repeated remote ischemic postconditioning on infarct size in patients with an ischemic stroke (REPOST): study protocol for a randomized clinical trial
title_full_unstemmed The effect of repeated remote ischemic postconditioning on infarct size in patients with an ischemic stroke (REPOST): study protocol for a randomized clinical trial
title_short The effect of repeated remote ischemic postconditioning on infarct size in patients with an ischemic stroke (REPOST): study protocol for a randomized clinical trial
title_sort effect of repeated remote ischemic postconditioning on infarct size in patients with an ischemic stroke (repost): study protocol for a randomized clinical trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419836/
https://www.ncbi.nlm.nih.gov/pubmed/30876432
http://dx.doi.org/10.1186/s13063-019-3264-0
work_keys_str_mv AT landmanthijs theeffectofrepeatedremoteischemicpostconditioningoninfarctsizeinpatientswithanischemicstrokerepoststudyprotocolforarandomizedclinicaltrial
AT schoonyvonne theeffectofrepeatedremoteischemicpostconditioningoninfarctsizeinpatientswithanischemicstrokerepoststudyprotocolforarandomizedclinicaltrial
AT warlemichiel theeffectofrepeatedremoteischemicpostconditioningoninfarctsizeinpatientswithanischemicstrokerepoststudyprotocolforarandomizedclinicaltrial
AT deleeuwfrankerik theeffectofrepeatedremoteischemicpostconditioningoninfarctsizeinpatientswithanischemicstrokerepoststudyprotocolforarandomizedclinicaltrial
AT thijssendick theeffectofrepeatedremoteischemicpostconditioningoninfarctsizeinpatientswithanischemicstrokerepoststudyprotocolforarandomizedclinicaltrial
AT landmanthijs effectofrepeatedremoteischemicpostconditioningoninfarctsizeinpatientswithanischemicstrokerepoststudyprotocolforarandomizedclinicaltrial
AT schoonyvonne effectofrepeatedremoteischemicpostconditioningoninfarctsizeinpatientswithanischemicstrokerepoststudyprotocolforarandomizedclinicaltrial
AT warlemichiel effectofrepeatedremoteischemicpostconditioningoninfarctsizeinpatientswithanischemicstrokerepoststudyprotocolforarandomizedclinicaltrial
AT deleeuwfrankerik effectofrepeatedremoteischemicpostconditioningoninfarctsizeinpatientswithanischemicstrokerepoststudyprotocolforarandomizedclinicaltrial
AT thijssendick effectofrepeatedremoteischemicpostconditioningoninfarctsizeinpatientswithanischemicstrokerepoststudyprotocolforarandomizedclinicaltrial